Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'
found
Abbott Laboratories CEO Robert Ford unpacked his company's latest quarterly report in a Thursday interview with CNBC's Jim Cramer.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.